Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1990
12/18/1990US4978332 Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
12/18/1990CA1278150C Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
12/18/1990CA1277933C Porcine growth hormone analogs
12/18/1990CA1277932C Human calcitonin precursor polyprotein structural gene
12/18/1990CA1277901C Means for treating herpes infections
12/17/1990WO1990015860A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
12/17/1990WO1990015821A1 Stabilized, potent grf analogs
12/17/1990CA2057895A1 Stabilized, potent grf analogs
12/16/1990WO1990015878A1 Immunoactive peptides and antibodies and their use in anti-allergy treatment
12/16/1990WO1990015870A1 Interleukin-7 receptors
12/16/1990WO1990015819A1 Irreversible bombesin antagonists
12/16/1990WO1990015613A1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
12/16/1990CA2034480A1 Irreversible bombesin antagonists
12/16/1990CA2033082A1 Interleukin-7 receptors
12/15/1990WO1990015619A1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS
12/13/1990WO1990015152A1 Monoclonal antibodies for inducing tolerance
12/13/1990WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles
12/13/1990WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition
12/13/1990WO1990015074A1 Methods for enhancing the rate of modification of metastable bonds
12/13/1990WO1990015072A1 Platelet aggregation inhibitors and related molecules
12/13/1990WO1990015069A2 Amino acid derivative anticonvulsant
12/13/1990WO1990014843A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy
12/13/1990WO1990014839A1 A process for treating infertility and an agent for use in the process
12/13/1990WO1990014836A1 Methods of improved skin care and the treatment of dermatological conditions
12/13/1990WO1990013660A3 Human monoclonal antibodies to sero-specific determinants of gram-negative bacteria
12/13/1990DE3922089A1 Neue proteine und ihre herstellung New proteins and their production
12/13/1990CA2056451A1 A process for treating infertility and an agent for use in the process
12/12/1990EP0402313A1 Novel endothelin derivative
12/12/1990EP0402300A2 Production of bacteria and yeast of hemoglobin and analogues thereof
12/12/1990EP0402203A2 Use of a statine derivative for treatment of ophthalmologic disorders
12/12/1990EP0402159A1 Polypeptide having thrombin inhibiting activity and process for the manufacture thereof
12/12/1990EP0402070A1 Crystalline r-h-GM-CSF and method for its preparation
12/12/1990EP0402068A1 Polypeptides and polypeptide analogues with inhibitory activity against human elastase
12/12/1990EP0402029A2 Monoclonal antibodies for post exposure treatment of rabies
12/12/1990EP0401997A1 Process to prepare metastasis-inhibitory factor
12/12/1990EP0401963A1 Phosphonopeptides with collagenase inhibiting activity
12/12/1990EP0401941A2 Hepatitis B virus surface antigen and production thereof
12/12/1990EP0401747A2 Use of rapamycin and derivatives and prodrugs thereof in the manufacture of a medicament for inhibiting transplant rejection in mammals
12/12/1990EP0401705A2 Use of an HMG CoA reductase inhibitor and/or a squalene synthetase inhibitor for treating peripheral atherosclerotic disease
12/12/1990EP0401676A1 Enzyme inhibitors
12/12/1990EP0401675A1 Enzyme inhibiting peptide derivatives
12/12/1990EP0401508A2 Proteinaseinhibitors, method for their preparation and pharmaceutical compositions containing them
12/12/1990EP0401507A1 Cyclic agonists of tachykinin
12/12/1990EP0401384A1 Chemically modified granulocyte colony stimulating factor
12/12/1990EP0401379A1 STABILIZED COMPOSITION OF INTERLEUKIN-1$g(b)
12/12/1990EP0401347A1 Use of transferrin to combat the toxic effects of endotoxins in endotoxemia.
12/12/1990EP0401301A1 Fatty acid-drug conjugate for delivery of the drug across the blood-brain barrier
12/12/1990EP0401253A1 2-amino acetamide derivatives
12/12/1990EP0401247A1 Monoclonal antibody specific to a novel mucin-like glycoprotein surface antigen on human carcinoma cells
12/12/1990EP0401232A1 A process for pasteurization of aqueous solutions of factor viii.
12/12/1990EP0394349A4 Wound healing
12/12/1990CN1047695A Production method of a kind of nutrition liquid
12/12/1990CA2018367A1 Purified enzyme and process therefor
12/11/1990US4977277 Intermediates for renin inhibitors
12/11/1990US4977245 Genetic engineered anticacinogenic agents
12/11/1990US4977244 Immunosuppressive, antiinflammatory agents
12/11/1990US4977179 Proline derivatives
12/11/1990US4977174 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
12/11/1990US4977168 Anticoagulants
12/11/1990US4977140 Injectable sustained release formulation
12/11/1990US4977139 Osteoporosis, Paget's disease
12/11/1990US4977138 FR901228 substance and preparation thereof
12/11/1990US4977137 Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
12/11/1990US4977083 Processes for preparing A54145 compounds
12/11/1990US4976962 Biodegradable polypeptide and the use thereof for the gradual release of drugs
12/11/1990US4976959 Synergistic combination of tissue plasminogen activator and superoxide dismutase
12/11/1990US4976957 Process for the production of recognins and their chemoreciprocals
12/11/1990US4976949 Controlled release dosage form
12/11/1990US4976734 Stimulation of chemotaxis by chemotactic peptides
12/11/1990CA1277623C Enkephalinase b inhibitors, their preparation, and pharmaceutical compositions containing the same
12/11/1990CA1277618C Bacteriolytic enzyme product from streptomyces, a process for its preparation, and a strain suitable for this purpose
12/11/1990CA1277617C Antibiotic polypeptide, process for preparing it and the use thereof
12/11/1990CA1277616C2 Hybrid human leukocyte interferons
12/11/1990CA1277613C Monoclonal antibodies, a process for their preparation and their use
12/11/1990CA1277612C Monoclonal antibodies with specificity for membrane- associated antigens
12/11/1990CA1277600C Tumor therapeutic agent and a process for its preparation
12/11/1990CA1277596C Continuous release peptide compositions
12/11/1990CA1277595C Method and composition for regulating serum calcium levels of mammals
12/11/1990CA1277594C Compounds having somatostatin-like activity useful as local anti-inflammatory agents
12/10/1990WO1990015142A1 Growth hormone fusion proteins
12/09/1990WO1990014886A1 Chemical products
12/09/1990CA2018458A1 Renin-inhibiting peptides
12/08/1990CA2018508A1 Mouse monoclonal antibodies for post-exposure treatment of rabies
12/08/1990CA2018453A1 Methods for enhancing the rate of modification of metastable bonds
12/07/1990WO1990015151A1 Crystalline r-h-gm-csf and method for the preparation
12/07/1990WO1990014841A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides
12/07/1990WO1990014840A1 Recombinant alzheimer's amyloid protein
12/07/1990CA2018248A1 Monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use
12/06/1990WO1990015078A1 HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120
12/06/1990WO1990014838A1 Treating disorders by application of insulin-like growth factors and analogs
12/06/1990DE3917852A1 Medikamente zur tumortherapie mit kontrolliertem und reguliertem immunsystem sowie verwendung der einzelsubstanzen zur kombinierten therapie Drugs for tumor therapy with controlled and regulated immune system as well as use of individual substances for combined therapy
12/06/1990DE3915952A1 Medicaments for treating diseases involving intracellular protein - comprising nucleic acid coding for antibody to protein
12/06/1990CA2058630A1 Human monoclonal antibodies to hiv-1 mn gp 120
12/06/1990CA2018112A1 Compounds
12/05/1990EP0401177A1 Synthetic peptide antagonists of neurokinin A, salts thereof and respective preparation processes
12/05/1990EP0401109A1 Microproteins, preparation thereof and use as a drug of these microproteins
12/05/1990EP0401055A2 Bone Calcification factor
12/05/1990EP0400762A1 Treating animals using IL-2, formulations therefor and their preparation
12/05/1990EP0400637A2 Preparation of FR115224 substance for parenteral administration
12/05/1990EP0400545A1 Derivative of tissue plasminogen activator